. . . . . . . . . . . . . "a(CHEBI:gefitinib) -| p(HGNC:CEP68,pmod(P,Y))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Of these, Endofin, DCBLD2, and KIAA0582 were validated to be novel tyrosine-phosphorylation targets of EGF signaling and Iressa, a highly selective inhibitor of EGFR." . . "Selventa" . . . . "2014-07-03T14:30:51.114+02:00"^^ . . .